AU2001232132A1 - Novel assay - Google Patents

Novel assay

Info

Publication number
AU2001232132A1
AU2001232132A1 AU2001232132A AU3213201A AU2001232132A1 AU 2001232132 A1 AU2001232132 A1 AU 2001232132A1 AU 2001232132 A AU2001232132 A AU 2001232132A AU 3213201 A AU3213201 A AU 3213201A AU 2001232132 A1 AU2001232132 A1 AU 2001232132A1
Authority
AU
Australia
Prior art keywords
novel assay
assay
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001232132A
Other languages
English (en)
Inventor
Andrew James Brown
Alan Wise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0003900A external-priority patent/GB0003900D0/en
Priority claimed from GB0007015A external-priority patent/GB0007015D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001232132A1 publication Critical patent/AU2001232132A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001232132A 2000-02-18 2001-02-19 Novel assay Abandoned AU2001232132A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0003900 2000-02-18
GB0003900A GB0003900D0 (en) 2000-02-18 2000-02-18 Assay
GB0007015 2000-03-22
GB0007015A GB0007015D0 (en) 2000-03-22 2000-03-22 Assay
PCT/GB2001/000684 WO2001061359A2 (fr) 2000-02-18 2001-02-19 Dosage biologique

Publications (1)

Publication Number Publication Date
AU2001232132A1 true AU2001232132A1 (en) 2001-08-27

Family

ID=26243682

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001232132A Abandoned AU2001232132A1 (en) 2000-02-18 2001-02-19 Novel assay

Country Status (4)

Country Link
US (1) US20030113810A1 (fr)
EP (1) EP1255779A2 (fr)
AU (1) AU2001232132A1 (fr)
WO (1) WO2001061359A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902902B2 (en) 2001-11-27 2005-06-07 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
WO2004038406A2 (fr) * 2002-10-24 2004-05-06 Bayer Healthcare Ag Diagnostic et therapie de maladies associees au recepteur 42 couple a la proteine g (gpr42) humain
AU2003267443A1 (en) * 2002-10-25 2004-05-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41)
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
CA2584224A1 (fr) * 2004-11-03 2006-05-18 Arena Pharmaceuticals, Inc. Gpr41 et modulateurs de celui-ci utilises dans le traitement de troubles lies a l'insuline
US8234219B2 (en) * 2008-09-09 2012-07-31 Applied Systems, Inc. Method, system and apparatus for secure data editing
EP2389439A4 (fr) * 2009-01-23 2013-02-13 Agency Science Tech & Res Polymorphisme d'un nucléotide simple au sein d'un motif de liaison à p53 intronique du gène prkag2
WO2014011926A1 (fr) 2012-07-11 2014-01-16 Elcelyx Therapeutics, Inc. Compositions comportant des statines, des biguanides et d'autres agents pour réduire un risque cardiométabolique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159700A (en) * 1997-01-27 2000-12-12 Smithkline Beecham Corporation Method of finding agonist and antagonist to human and rat GPR14
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors

Also Published As

Publication number Publication date
WO2001061359A2 (fr) 2001-08-23
US20030113810A1 (en) 2003-06-19
WO2001061359A3 (fr) 2002-03-28
EP1255779A2 (fr) 2002-11-13

Similar Documents

Publication Publication Date Title
AU2002218331A1 (en) Bioanalytical assay
AU2002353861A1 (en) Assay
AU2002359392A1 (en) Rapid prion-detection assay
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001232132A1 (en) Novel assay
AU2001232041A1 (en) Improved assay
GB0012860D0 (en) Assay
AU1531801A (en) Novel assay
AU2002221132A1 (en) Novel antibody
AU2001240793A1 (en) Novel assay
AU7537400A (en) Assay
AU4670901A (en) Homocysteine assay
AU5240901A (en) Assay
AU2001268264A1 (en) Resazurin-based cytotoxicity assay
GB0003902D0 (en) Assay
GB0005894D0 (en) Assay
AUPQ943700A0 (en) Micronucleus assay
AU2002219846A1 (en) Novel use
AU3389501A (en) Assay
AU2001276499A1 (en) Assay
AU2001274750A1 (en) Novel beta-hydroxyamides
GB0001703D0 (en) Assay
GB0025804D0 (en) Assay
AU2001279721A1 (en) Structural member
GB0023239D0 (en) Assay